← Eichor
Study identifier: NCT06039917 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions

Condition: Artificial Intelligence · Surveillance  ·  Sponsor: Renmin Hospital of Wuhan University

PhaseNA
Planned participants1460
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.

This description comes directly from the study's public registry record.

Talk to the study team

Honggang Yu, PhD  ·  13871281899  ·  yuhonggang1968@163.com

Always discuss trial participation with your own doctor first.

Locations (4)

Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian CampusQuanzhou, Fujian, ChinaNot Yet Recruiting
The Eighth Hospital of WuhanWuhan, Hubei, ChinaNot Yet Recruiting
Renmin Hospital of Wuhan UniversityWuhan, Hubei, ChinaRecruiting
Shanghai Pudong HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06039917